Hypothyroidism caused by thalidomide [3]

Indian Journal of Medical Sciences

Volumn 60, Issue 10, 2006, Pages 424-426

  Chowta, Mukta N ^a   Chowta, Nithyananda K ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; THALIDOMIDE; THYROID HORMONE; THYROXINE; VINCRISTINE;

ADULT; AMENORRHEA; CASE REPORT; CLINICAL FEATURE; EDEMA; FEMALE; FOLLOW UP; HOARSENESS; HUMAN; HYPOTHYROIDISM; LETTER; MULTIPLE MYELOMA; OBESITY; PATIENT MONITORING; SCORING SYSTEM; THYROID FUNCTION;

EID: 33749398082     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.27675     Document Type: Letter

References (5)

1. Kyle RA. Current therapy of multiple myeloma. Intern Med 2002;41:175-80.
2. Singhal S, Mehta J. Thalidomide in cancer: Potential uses and limitations. Bio Drugs 2001;15:163-72.
3. Naranjo CA, Busto U, Sellen EM, Sandos P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactiond. Clin Pharmacol Ther 1981;30:239-45.
4. Badros AZ, Siegel E, Bodenner D, Zangari M, Zeldis J, Barlogie B, et al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med 2002;112:412-3.
5. de Savary N, Lee R, Vaidya B. Severe hypothyroidism after thalidomide treatment. J R Soc Med 2004;97:443.